BD invested $10 million last year to increase manufacturing capacity. The recent expansion has created more than 200 jobs.

Version Report "Disposable Syringes Market Size, Statistics, Growth Trend Analysis, and Forecast Report, 2025 – 2034" ...

This comes after the Maine CDC suspended and later revoked HEAL's syringe exchange certification for all sites in Bangor, ...

day-old baby endures 24 days of pain after needle found in leg post vaccination, sparking negligence accusations at hospital.

Becton, Dickinson and Co. (BD) is investing in its U.S. manufacturing network to add capacity for critical medical devices, ...

CAMBRIDGE, MA, USA & BRISBANE, Australia I2, 2025 I Vaxxas, a clinical-stage biotechnology company commercializing a novel high-density ...

The needle-free injectors market is projected to grow at 12% annually, reaching USD 42.79 billion by 2032. Increasing ...

Cosmetic injectables are practically ubiquitous but still somehow shrouded in mystery. We want to feel confident, look good, ...

Harm reduction” programs have significantly impacted cities across the country, with synthetic drug deaths from substances like fentanyl and methamphetamine at historic highs.

Clinical-stage Australian biotechnology company Vaxxas will receive $3.2 million from the US Biomedical Advanced Research and ...

A man who injected a record shop owner with a muscle relaxant used as a medical anaesthetic was a "senior member" of a ...

A medical expert, who testified Tuesday in the murder trial of Natalie Cochran, stated that for a blood glucose level to ...